Answer: B (Insulinoma)
Discussion:
Insulinomas are the most common neuroendocrine tumors of the pancreas and can occur sporadically or in association with MEN 1 syndrome. They manifest with hypoglycemic symptoms, and elevated plasma insulin and C-peptide levels indicate excessive insulin production. Imaging modalities like contrast-enhanced CT, MRI, and nuclear medicine scans are used to identify and stage insulinomas.
Nuclear medicine techniques for insulinoma imaging include tracers such as 111In-Pentetreotide, 68Ga DOTATATE, 18F-FDOPA, and more recently, glucagon-like-peptide-1 (GLP-1) agents. Although 18F-FDOPA has been commonly used, its limited suitability in adults due to pancreatic uptake affects its tumor detection accuracy. 68Ga DOTA-Exendin PET/CT has emerged as a promising approach for preoperative and intraoperative localization of insulinomas, as they typically express GLP-1 receptors.
In cases of persistent hyperinsulinemic hypoglycemia (PHH) in adults where no identifiable lesion is found, the diagnosis may be nesidioblastosis. Nesidioblastosis involves diffuse proliferation of beta islet cells throughout the pancreas and poses challenges in localization using imaging techniques.